<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Homeostasis of the brain is dependent on the blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>This barrier tightly regulates the exchange of essential nutrients and limits the free flow of immune cells into the <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Perturbations of <z:chebi fb="2" ids="33602">BBB</z:chebi> function and the loss of its immune quiescence are hallmarks of a variety of <z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">brain diseases</z:e>, including multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> (MS), vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, and <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In particular, diapedesis of monocytes and subsequent trafficking of monocyte-derived macrophages into the brain are key mediators of <z:hpo ids='HP_0011096'>demyelination</z:hpo> and axonal damage in MS </plain></SENT>
<SENT sid="4" pm="."><plain>Endothelin-1 (ET-1) is considered as a potent pro-inflammatory <z:chebi fb="7" ids="16670">peptide</z:chebi> and has been implicated in the development of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Here, we studied the role of different components of the endothelin system, i.e., ET-1, its type B receptor (ET(B)) and endothelin-converting enzyme-1 (ECE-1) in monocyte diapedesis of a human brain endothelial cell barrier </plain></SENT>
<SENT sid="6" pm="."><plain>Our pharmacological inhibitory and specific gene knockdown studies point to a regulatory function of these proteins in transendothelial passage of monocytes </plain></SENT>
<SENT sid="7" pm="."><plain>Results from this study suggest that the endothelin system is a putative target within the brain for anti-inflammatory treatment in <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological diseases</z:e> </plain></SENT>
</text></document>